BIOMARIN PHARMACEUTICAL INC Asset Retirement Obligation, Liabilities Incurred
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Asset Retirement Obligation, Liabilities Incurred of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Notes › Asset Retirement Obligations
us-gaap:AssetRetirementObligationLiabilitiesIncurred · last filed 2017-02-27
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, liabilities incurred for the quarter ending 2015-12-31 was $72.00K.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, liabilities incurred for the quarter ending 2015-09-30 was $636.00K.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, liabilities incurred for the quarter ending 2015-06-30 was $28.00K.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, liabilities incurred for the quarter ending 2015-03-31 was $84.00K.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, liabilities incurred for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, liabilities incurred for fiscal 2015 was $820.00K.
| Period end | Asset Retirement Obligation, Liabilities Incurred 3 month | Asset Retirement Obligation, Liabilities Incurred 6 month | Asset Retirement Obligation, Liabilities Incurred 9 month | Asset Retirement Obligation, Liabilities Incurred 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-27 | |||
| 2015-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $708.00K derived: sum of 2 quarters · filed 2016-02-29 | $736.00K derived: sum of 3 quarters · filed 2016-02-29 | $820.00K 10-K · filed 2016-02-29 |
| 2015-09-30 | $636.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $664.00K derived: sum of 2 quarters · filed 2015-11-02 | $748.00K 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $112.00K 10-Q · filed 2015-08-05 | ||
| 2015-03-31 | $84.00K 10-Q · filed 2015-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |